MC1435A1 - Procede pour la preparation de derives de la pyrazoline et produits contenant ces substances - Google Patents

Procede pour la preparation de derives de la pyrazoline et produits contenant ces substances

Info

Publication number
MC1435A1
MC1435A1 MC811566A MC1566A MC1435A1 MC 1435 A1 MC1435 A1 MC 1435A1 MC 811566 A MC811566 A MC 811566A MC 1566 A MC1566 A MC 1566A MC 1435 A1 MC1435 A1 MC 1435A1
Authority
MC
Monaco
Prior art keywords
formula
pyrazoline
compound
trifluoromethylphenyl
methyl
Prior art date
Application number
MC811566A
Other languages
English (en)
French (fr)
Inventor
F C Copp
D Collard
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1435A1 publication Critical patent/MC1435A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MC811566A 1980-12-16 1981-12-15 Procede pour la preparation de derives de la pyrazoline et produits contenant ces substances MC1435A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8040172 1980-12-16
US25607281A 1981-04-21 1981-04-21

Publications (1)

Publication Number Publication Date
MC1435A1 true MC1435A1 (fr) 1982-12-06

Family

ID=26277856

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811566A MC1435A1 (fr) 1980-12-16 1981-12-15 Procede pour la preparation de derives de la pyrazoline et produits contenant ces substances

Country Status (18)

Country Link
EP (1) EP0055418B1 (enExample)
AT (1) AT379803B (enExample)
AU (1) AU559488B2 (enExample)
CA (1) CA1180335A (enExample)
CH (1) CH654209A5 (enExample)
DE (2) DE3173933D1 (enExample)
DK (1) DK556381A (enExample)
ES (1) ES507975A0 (enExample)
FI (1) FI814024L (enExample)
FR (1) FR2496100B1 (enExample)
GR (1) GR76989B (enExample)
HU (1) HU187392B (enExample)
IE (1) IE51951B1 (enExample)
IL (1) IL64555A (enExample)
MC (1) MC1435A1 (enExample)
NL (1) NL8105652A (enExample)
NZ (1) NZ199288A (enExample)
SE (1) SE8107524L (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070376A1 (en) * 1981-07-13 1983-01-26 American Cyanamid Company Heterocyclic substituted-amino-pyrazolines
GB8303782D0 (en) * 1983-02-11 1983-03-16 Wellcome Found Heterocyclic compounds
DK60684A (da) * 1983-02-11 1984-08-12 Wellcome Found Fremgangsmaade til fremstilling af 3-(n-substitueret amino)-2-pyrazoliner og mellemprodukter anvendelige ved udoevelse af fremgangsmaaden
US4824859A (en) * 1983-05-21 1989-04-25 Fisons Plc. Pyrazoline compounds compositions and use
DE3575130D1 (de) * 1984-05-12 1990-02-08 Fisons Plc Antiinflammatorische 1,n-diarylpyrazol-3-amine, deren zusammensetzungen und verfahren zu deren herstellung.
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
FR2781147B1 (fr) 1998-07-20 2000-09-15 Oreal Compositions pour la teinture des fibres keratiniques contenant des derives de 3-amino pyrazolines a titre de coupleur, procede de teinture et kit de teinture
GB0603181D0 (en) * 2006-02-17 2006-03-29 Merck Sharp & Dohme Treatment of neurodegenerative and psychiatric diseases
WO2025166015A2 (en) * 2024-02-02 2025-08-07 Photys Therapeutics, Inc. Bifunctional abl1-binding compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT260924B (de) * 1964-05-27 1968-03-25 Geigy Ag J R Verfahren zur Herstellung von neuen Pyrazolinverbindungen
FR2059449A1 (enExample) * 1969-02-26 1971-06-04 Synthelabo
CA1150632A (en) * 1979-07-13 1983-07-26 John M.G. Walker 3-amino-pyrazoline derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0055418A2 (en) 1982-07-07
CH654209A5 (de) 1986-02-14
AU7851081A (en) 1982-06-24
DK556381A (da) 1982-06-17
NL8105652A (nl) 1982-07-16
AU559488B2 (en) 1987-03-12
AT379803B (de) 1986-03-10
FI814024A7 (fi) 1982-06-17
IL64555A0 (en) 1982-03-31
DE3173933D1 (en) 1986-04-03
IE51951B1 (en) 1987-04-29
FI814024L (fi) 1982-06-17
IE812944L (en) 1982-06-16
HU187392B (en) 1985-12-28
EP0055418B1 (en) 1986-02-26
SE8107524L (sv) 1982-06-17
ATA537281A (de) 1985-07-15
DE3149710A1 (de) 1982-08-05
CA1180335A (en) 1985-01-02
EP0055418A3 (en) 1982-08-18
ES8307224A1 (es) 1983-06-16
IL64555A (en) 1986-01-31
FR2496100A1 (fr) 1982-06-18
GR76989B (enExample) 1984-09-04
NZ199288A (en) 1985-07-31
FR2496100B1 (fr) 1985-06-14
ES507975A0 (es) 1983-06-16

Similar Documents

Publication Publication Date Title
BE898570A (fr) Nouveaux amides et imides carboxyliques, procédés pour leur préparation et composition pharmaceutique les contenant.
EP0012639B1 (fr) Nouveaux dérivés de l'acide 3-quinoléine carboxylique, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant
FR2762514A1 (fr) Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
EP1148881B1 (fr) UTILISATION DE DERIVES DE PYRIDAZINO ¬4,5-(b)|-INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2665441A1 (fr) Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
MC1628A1 (fr) Nouvelles triazines et leur preparation
EP0116494B1 (fr) Dérivés de la pyridazine ayant une action psychotrope, procédé d'obtention, intermédiaires et médicaments en contenant
MC1435A1 (fr) Procede pour la preparation de derives de la pyrazoline et produits contenant ces substances
LU83576A1 (fr) Nouveaux derives du 4h-1,2,4-triazole,leur preparation,leur application comme medicament,les compositions les renfermant et les intermediaires obtenus
CH635832A5 (fr) Derives du tetrazole et composition pharmaceutique les contenant.
EP0114850B1 (fr) Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
EP0156734A2 (fr) Triazolo[4,3-b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2526434A1 (fr) Nouveaux azepino-indoles, leur preparation et leur utilisation comme medicaments
EP0880522B1 (fr) DERIVES DE 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-4-ONE ANTAGONISTES DES RECEPTEURS AMPA ET NMDA, LEUR PREPARATION, LEURS INTERMEDIAIRES ET LES MEDICAMENTS LES CONTENANT
MC511A1 (fr) Nouveaux composés hétérocycliques et leur préparation
CH659469A5 (fr) Derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation et les medicaments et compositions les renfermant.
CA2130095A1 (fr) Application de derives d'acide 2h-1,2,4-benzothiadiazine-1, 1-dioxyde-3-carboxylique a la preparation de medicaments, les produits nouveau, leur preparation et les medicaments lescontenant
LU87129A1 (fr) Nouvel acide piperazinecarboxylique,sa preparation et son utilisation comme medicament
EP0151140B1 (fr) Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant
LU83928A1 (fr) Acides amino-2 halogenobenzoyl-3 methyphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
MC2108A1 (fr) Derives de quinoleine
MC1185A1 (fr) Derives de quinazoline
EP1492792B1 (fr) Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide,leur preparation et leur application en therapeutique
MC1287A1 (fr) Derives de cyclohexadiene
CA2557942C (fr) Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
YP Annual fee paid